At MediMix, we are dedicated to keeping Belgian healthcare professionals at the forefront of medicine. Our team brings you high-value insights from leading congresses worldwide, across key disease areas including dermatology. In collaboration with Belgian and international experts, we transform the latest data into practical knowledge.
Dr Lucas Boussingault performed a
retrospective analysis on LC-OCT images obtained prior to biopsy in twenty male patients presenting with penile erythematous lesions. Preliminary findings suggest that inflammatory dermatoses
Prof Dr Nanja van Geel discusses some recent scientific advances and clinical developments that were highlighted during the EADV Congress.
Chimeric antigen receptor (CAR) T-cell therapy has rapidly emerged as a groundbreaking development in oncology and is increasingly being investigated for autoimmune diseases, including dermatological conditions. CAR T-cells are genetically
Dr Tom Hillary was one of the PI of the Olympia study, evaluating the efficacy and safety of nemolizumab compared with placebo during the induction phase. Clinical outcomes were striking.
Prof Reinhart Speackaert interviews Dr Florence Bourlond about her clinical experience with topical ruxolitinib.
Initial clinical experiences are highly encouraging, with patients frequently reporting visible repigmentation after approximately six
Prof Cédric Lenormand, one of the presenters during the first plenary session of EADV, discussed VEXAS syndrome with Prof Jan Gutermuth, highlighting key insights for dermatologists. Vexas syndrome is a
Dr Valerie Reynaert shared key highlights on CLE from a dedicated session at EADV. The session offered a rich overview of clinical cases, diagnostic considerations, and especially the rapidly evolving
Dr Roquet-Gravy summarised some recent advances in the management of hair disorders presented at EADV, offering valuable updates for clinical practice.
Psoriasis remains a complex chronic inflammatory disease requiring a diverse therapeutic armamentarium. Despite the widespread use of biologics, phototherapy continues to be discussed as a viable option. Narrowband UVB (NB-UVB)
During the recent vitiligo session at the EADV, where Prof Speeckaert gave the first presentation, several key aspects were discussed. Vitiligo remains a highly heterogeneous disorder, and its management requires
During EADV 2024, Dr Elise Vandersichel, dermatologist at the University Hospital Brussels with a special interest for psychodermatology presented two posters focusing on the factors that influence the development of
During EADV 2024, Prof Dr Lidija Kandolf-Sekulovic, dermatologist at the Military Medicine Academy in Belgrade (Serbia) gave an overview of emerging therapies for patients with cutaneous squamous cell carcinoma (CSCC),
During the 2024 EADV congress, Dr Thomas Damsin, dermatologist at the CHU Liège discussed the preliminary results of the TELESPOT project. In this project, teledermoscopy (TDS) to triage and expedite
Chris Callewaert is a researcher at the Ghent University Hospital who studies the relationship between the skin microbiome and skin disease. In this capacity he is doing research into the
During EADV 2024, Prof Dr Emily Ruiz discussed innovative strategies to do a better job in risk stratifying CSCC patients. The traditional BWH staging for patients with CSCC looks at
Ms Elfie Deprez is a nurse specialist working at the dermatology department of the Ghent University Hospital. In this video she explains how they are using value-based healthcare to improve
Chris Callewaert is a researcher at the Ghent University Hospital who studies the relationship between the skin microbiome and skin disease. In this capacity he was asked to give a
During EADV 2024, Dr Christa De Cuyper, former clinical dermatologist at the AZ Sint-Jan in Bruges with a special interest for dermatological complications of body art, provided an overview of
Mohs surgery is a specific type of surgery to remove different types of skin cancer by cutting away thin layers of skin until negative margins are obtained. For patients with
Over the last years, artificial Intelligence (AI) is steadily transforming the healthcare landscape and dermatology has been at the forefront of this evolution. During a plenary lecture at EADV 2024,
Vascular malformations arise from defects during early vascular development and lead to the formation of abnormally structured vessels. These malformations can significantly impact the quality of life of patients and
Dermatology is a medical field that is often plagued by fragmented care and ineffective referral. During the 2024 EADV congress, Dr Menno Gaastra explained how he sees a closer collaboration
During the first plenary session at EADV 2024, Prof Dr Henry de Vries, dermatologist at the Amsterdam University Medical Center with a special interest for sexually transmitted diseases (STDs), discussed
During the 2024 EADV congress, Prof Dr Jan Gutermuth, dermatologist at the University Hospital Brussels, chaired an interesting pro-con session in which 2 hot topics in dermatology were discusses.
MediMix aims to bring high value medical information to Belgian healthcare professionals via multiple channels.
MediMix covers congresses and symposia all over the world, with a particular focus on the dermatology specialist. In collaboration with Belgian and international experts, we will bring the newest data to Belgian physicians, with focus on the impact on clinical practice.
